Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Medidata Solutions Inc    MDSO

Delayed Quote. Delayed  - 08/26 09:47:01 pm
53.82 USD   +1.07%
08/03 MEDIDATA SOLUTI : Pluristem Therapeutics Deploys Medidata's Cloud Te..
08/03 MEDIDATA SOLUTI : Pluristem Therapeutics Deploys Medidata’s Cl..
08/02 MEDIDATA : to Present at Pacific Crest Global Technology Leadership ..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Medidata Solutions Inc : Medidata Solutions Announces Two-for-One Stock Split

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/11/2013 | 12:31pm CEST

Medidata Solutions (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that its Board of Directors approved a two-for-one (2:1) split of the Company's common stock at a regularly scheduled board meeting on November 7, 2013. The stock split will be structured in the form of a stock dividend.

The record date for the stock split is December 2, 2013. Shareholders of record as of such date will receive one new share of common stock for each share that they own. The distribution of the new shares will be made on December 16, 2013, and trading on a split-adjusted basis is expected to begin on or about December 17, 2013.

Medidata had approximately 26.8 million shares of common stock outstanding as of November 7, 2013. The stock split will increase the common shares outstanding to approximately 53.6 million.

About Medidata Solutions

Medidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud TM brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of our global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.

Investors:
Medidata Solutions
Hulus Alpay, 212-419-1025
halpay@mdsol.com
or
Media:
Medidata Solutions
Gail Janowitz, 212-918-1792
gjanowitz@mdsol.com


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDIDATA SOLUTIONS INC
08/15 MEDIDATA SOLUTIONS, INC. : Change in Directors or Principal Officers, Financial ..
08/05 MEDIDATA SOLUTIONS : Management's Discussion and Analysis of Financial Condition..
08/03 MEDIDATA SOLUTIONS : Pluristem Therapeutics Deploys Medidata's Cloud Technology
08/03 MEDIDATA SOLUTIONS : Pluristem Therapeutics Deploys Medidata’s Cloud Techn..
08/02 MEDIDATA : to Present at Pacific Crest Global Technology Leadership Conference
08/01 MEDIDATA SOLUTIONS : April Mulroney Honored Among PharmaVOICE 100's Most Inspiri..
08/01 MEDIDATA : ’s April Mulroney Honored Among PharmaVOICE 100’s Most In..
07/31 MEDIDATA SOLUTIONS : University of Southampton awarded 0.6 Million GBP contract ..
07/28 MEDIDATA SOLUTIONS : New Cancer-Focused Biotech Forty Seven Inc. Selects Medidat..
07/22 MEDIDATA : Cloud Technology Selected to Support Biogen Clinical Trials
More news
Sector news : IT Services & Consulting - NEC
03:55p Apollo Global to take Rackspace private in $4.3 billion deal
11:35a GfK majority owner denies considering stake sale
08/25DJChina Sets New Tone in Drafting Cybersecurity Rules
08/25DJMylan Boosts Price Assistance for EpiPen Amid Backlash
08/24DJChip Rivals Make New Challenge on Intel -- WSJ
More sector news : IT Services & Consulting - NEC
News from SeekingAlpha
07/20 TECHNOLOGY - TOP 5 GAINERS / LOSERS : 00 pm
07/20 Medidata Solutions (MDSO) Tarek A. Sherif on Q2 2016 Results - Earnings Call ..
07/20 Medidata Solutions +10% on EPS, revenue beat
07/20 Medidata Solutions beats by $0.01, beats on revenue
07/19 Notable earnings before Wednesday?s open
Advertisement
Financials ($)
Sales 2016 462 M
EBIT 2016 99,1 M
Net income 2016 20,1 M
Debt 2016 31,9 M
Yield 2016 -
P/E ratio 2016 149,70
P/E ratio 2017 112,27
EV / Sales 2016 6,69x
EV / Sales 2017 5,49x
Capitalization 3 061 M
More Financials
Chart MEDIDATA SOLUTIONS INC
Duration : Period :
Medidata Solutions Inc Technical Analysis Chart | MDSO | US58471A1051 | 4-Traders
Full-screen chart
Technical analysis trends MEDIDATA SOLUTION...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 57,2 $
Spread / Average Target 7,5%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Tarek A. Sherif Chairman & Chief Executive Officer
Glen Michael de Vries President & Director
Michael L. Capone Chief Operating Officer
Rouven Bergmann Chief Financial & Accounting Officer
Andrew Newbigging Senior Vice President-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MEDIDATA SOLUTIONS INC8.03%3 106
INTERNATIONAL BUSINESS..15.27%152 027
TATA CONSULTANCY SERVI..5.79%75 544
INFOSYS LTD-4.68%36 025
COGNIZANT TECHNOLOGY S..-4.08%35 002
VMWARE, INC.31.75%31 699
More Results